AnPac Bio Sets Record Test Volume in Q3, and Forecasts ~ 100% Revenue Growth in 2020
November 25, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Anpac Bio Announces Appointment of New Independent Director
November 16, 2020 16:01 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Insights on the Breast Cancer Screening Market in North America to 2027 - by Test Type, End-user and Countries
November 05, 2020 08:53 ET
|
Research and Markets
Dublin, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The "North America Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Test Type; End User, and Countries" report has...
Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer
October 26, 2020 06:45 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United...
AnPac Bio to Receive Up To USD $8 Million Dollar Grants and Award for R&D, Product Commercialization, and Milestone Achievements
October 07, 2020 07:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million
October 01, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Global Next-Generation Breast Cancer Diagnostic and Screening Market 2020-2030: Focus on Products, Technologies, Cancer Sub-Type, End Users,, and Competitive Landscape
September 17, 2020 04:08 ET
|
Research and Markets
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The "Global Next-Generation Breast Cancer Diagnostic and Screening Market: Focus on Products, Technologies, Cancer Sub-Type, End Users, Country Data (14...
AnPac Bio Receives Major Immunology Testing Contract
September 15, 2020 07:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Reports First Six Months of 2020 Financial Results
September 10, 2020 06:53 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio to Report its First Six Months 2020 Financial Results on Thursday, September 10, 2020
August 28, 2020 08:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Aug. 28, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...